Quadriplegic areflexic ICU illness: Selective thick filament loss and normal nerve histology

Muscle and Nerve

Volumn 26, Issue 4, 2002, Pages 499-505

  Sander, Howard W ^a,b,c   Golden, Marianna ^d   Danon, Moris J ^b,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d BURKE REHABILITATION HOSPITAL   (United States)

Author keywords

Acute quadriplegic myopathy; Critical illness; Myopathy; Neuropathy; Thick filament loss

Indexed keywords

STEROID;

ADULT; AREFLEXIA; ARTICLE; BIOPSY; CLINICAL ARTICLE; CRITICAL ILLNESS; DISEASE ASSOCIATION; ELECTROMYOGRAPHY; ELECTRON MICROSCOPY; FEMALE; HISTOLOGY; HUMAN; INTENSIVE CARE; MALE; MOTOR NERVE; MOTOR UNIT POTENTIAL; MYOFILAMENT; OBTURATOR NERVE; POLYNEUROPATHY; PRIORITY JOURNAL; QUADRIPLEGIA;

ADULT; AGED; CRITICAL ILLNESS; ELECTRODIAGNOSIS; FEMALE; HUMANS; INTENSIVE CARE; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; MUSCLE, SKELETAL; MYOSINS; NEURONS; PERIPHERAL NERVES; PLASTIC EMBEDDING; QUADRIPLEGIA; REFLEX; SURAL NERVE;

EID: 0036789446     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10233     Document Type: Article

References (29)

1. Bailey JL, Wang X, England BK, Price SR, Ding X, Mitch WE. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest 1996;97:1447-1453.
2. Barohn RJ, Jackson CE, Rogers SJ, Ridings LW, McVey AL. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle Nerve 1994;17:647-654.
3. Carpenter S, Karpati G. Pathology of skeletal muscle. New York: Oxford University Press; 2001. p 64-75.
4. Danon MJ, Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991;14:1131-1139.
5. Deconinck N, Van Parijs V, Beckers-Bleukx G, Van den Bergh P. Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents. Neuromusc Disord 1998;8:186-192.
6. Engel AG, Franzini-Armstrong C, editors. Myology: basic and clinical, 2nd ed. New York: McGraw-Hill; 1994. p 984-988.
7. Hanson P, Dive A, Brucher JM, Bisteau M, Dangoisse M, Deltombe T. Acute corticosteroid myopathy in intensive care patients. Muscle Nerve 1997;20:1371-1380.
8. Kuncl RW, George EB. Toxic neuropathies and myopathies. Curr Opin Neurol 1993;6:695-704.
9. Kuntzer T, Schaller MD, Vuadens P, Janzer RC. Recurrent acute quadriplegic myopathy with myosin deficiency. Muscle Nerve 1998;21:266-267.
10. Lacomis D, Zochodne DW, Bird SJ. Critical illness myopathy. Muscle Nerve 2000;23:1785-1788.
11. Larsson L, Li X, Edstrom L, Eriksson LI, Zackrisson H, Argentini C, Schiaffino S. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Crit Care Med 2000;28:34-45.
12. Leijten FS, Harinck-de Weerd JE, de Weerd AW. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 1995;274:1221-1225.
13. Lindenbaum Y, Nations SP, Barohn RJ, Wolfe GI. Recurrent critical illness myopathy in an asthmatic patient treated with corticosteroids. J Clin Neuromusc Dis 2000;1:145-146.
14. MacFarlane LA, Rosenthal FD. Severe myopathy after status asthmaticus. Lancet 1977;2:615.
15. May RC, Kelly RA, Mitch WE. Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. J Clin Invest 1986;77:614-621.
16. Op de Coul AA, Verheul GA. Critical illness polyneuromyopathy. Clin Neurol Neurosurg 1994;96:261-263.
17. Primavera A, Abbruzzese M, Sandrock A. Case 11-1997: critical-illness myopathy. N Engl J Med 1997;337:862-863.
18. Ramsay DA, Zochodne DW, Robertson DM, Nag S, Ludwin SK. A syndrome of acute severe muscle necrosis in intensive care unit patients. J Neuropathol Exp Neurol 1993;52:387-398.
19. Rich MM, Bird SJ, Raps EC, McCluskey LF, Teener JW. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 1997;20:665-673.
20. Rich MM, Pinter MJ. Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann Neurol 2001;50:26-33.
21. Saadeh PB, Sander HW. Phrenic nerve conduction studies in the intensive care unit. Muscle Nerve 1996;19:1057.
22. Sander HW, Saadeh PB, Chandswang N, Greenbaum D, Chokroverty S. Diaphragmatic denervation in intensive care unit patients. Electromyogr Clin Neurophysiol 1999;39:3-5.
23. Sandrock AW Jr, Cros DP, Louis DN. Case records of the Massachusetts General Hospital. Case 11-1997: a 51-year-old man with chronic obstructive pulmonary disease and generalized muscle weakness. N Engl J Med 1997;336:1079-1088.
24. Sher JH, Shafiq SA, Schutta HS. Acute myopathy with selective lysis of myosin filaments. Neurology 1979;29:100-106.
25. Showalter CJ, Engel AG. Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 1997;20:316-322.
26. Zifko UA. Long-term outcome of critical illness polyneuropathy. Muscle Nerve 2000;Suppl 9:S49-S52.
27. Zifko UA, Zipko HT, Bolton CF. Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci 1998;159:186-193.
28. Zochodne DW, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, Sibbald WA. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 1987;110:819-841.
29. Zochodne DW, Ramsay DA, Saly V, Shelley S, Moffatt S. Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 1994;17:285-292.